Atezolizumab and bevacizumab: the revolutionary duo as a game changer in advanced hepatocellular carcinoma

• D.X. Zhang

Affiliations

D.X. Zhang

Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR; Department of Molecular Biology and Genetics, Cornell University, Ithaca, USA